|
2007228 |
5-Fluorouracil (5-FU) Toxicity and Chemotherapeutic Response, 7 Mutations |
|
5-Fluorouracil Sensitivity |
5-FU, 5-Fluorouracil Toxicity and Chemotherapeutic Response Panel, Pharmacogenetics (PGx), Colorectal Cancer |
|
2006102 |
ALK Gene Rearrangements in NSCLC for Crizotinib Eligibility by FISH |
|
ALK Gene Rearrangements |
ALK GENE, Lung cancer, pharmcogenetics, pulmonary cancer |
|
2004547 |
EML4/ALK Translocation by RT-PCR |
Additional Technical Information |
ALK Gene Rearrangements |
EGFR RFLX, Lung Cancer, ALK gene, crizotinib, pulmonary cancer |
|
0040138 |
BCR-ABL1 Kinase Domain Mutation Analysis |
Additional Technical Information |
BCR-ABL1 |
Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), Tumor Markers |
|
2002298 |
BCR/ABL1 Fusion t(9;22)(q34;q11.2) by FISH |
|
BCR-ABL1 |
|
|
2002498 |
BRAF codon 600 Mutation Detection by Pyrosequencing |
Additional Technical Information |
BRAF codon 600 |
Melanoma, Colorectal cancer, Lynch Syndrome, HNPCC, Hereditary Nonpolyposis Colorectal Cancer, Gastrointestinal Adenocarcinoma, Papillary thyroid carcinoma |
|
2004247 |
CEBPA Mutation Detection |
Additional Technical Information |
CEBPA Mutation |
Acute Myelogenous Leukemia (AML) |
|
0051232 |
Cytochrome P450 2D6 (CYP2D6) 14 Mutations and Gene Duplication |
|
Cytochrome P450 |
CYP 2D6, Tamoxifen, Pharmacogenetics (PGx), Schizophrenia, Breast Cancer, breast biomarkers |
|
0051104 |
Cytochrome P450 2C19 (CYP2C19) 9 Mutations |
|
Cytochrome P450 |
CYP2C19, Pharmacogenetics (PGx), Schizophrenia, Breast Cancer, breast biomarkers |
|
0051103 |
Cytochrome P450 2C9 (CYP2C9) 2 Mutations |
Additional Technical Information |
Cytochrome P450 |
CYP2C9, Warfarin Sensitivity, Pharmacogenetics (PGx) |
|
2002440 |
EGFR Mutation Detection by Pyrosequencing |
Additional Technical Information |
EGFR Mutation |
Lung Cancer |
|
2002674 |
Gastrointestinal Stromal Tumor Mutation |
Additional Technical Information |
Gastrointestinal Stromal Tumors (GIST) |
Gastrointestinal Stromal Tumors (GIST) |
|
0080135 |
Glucose-6-Phosphate Dehydrogenase |
Additional Technical Information |
Glucose-6-Phosphate Dehydrogenase |
G6PD, Dapsone, Flutamide, Mafenide cream, Methylene blue, Nalidixic acid, Nitrofurantoin, Phenazopyridine, Primaquine, Rasburicase, Sulfacetamide, Sulfamethoxazole, Sulfanilamide
|
|
0049390 |
ERBB2 (HER-2/neu) Gene Amplification by PCR |
Additional Technical Information |
HER-2/neu Gene Amplification |
Tumor Markers, FISH, herceptin, HER2, HER-2, neu, HER2/neu |
|
2002429 |
HLA-B*5701 Associated Variant Genotyping for Abacavir Sensitivity |
|
HLA-B*5701 (Abacavir Sensitivity) Genotyping |
HLA-B5701, Pharmacogenetics (PGx), HIV Drug Resistance, HIV, Abacavir sensitivity, Ziagene, Abacavir hypersensitivity, ABC HSR |
|
2004680 |
Interleukin 28 B (IL28B)—Associated Variants, 2SNPs |
|
Interleukin 28 B Associated SNP—Genotyping |
IL28B, Hepatitis C Virus (HCV), peginterferon, interferon, PEG-IFNα |
|
2002357 |
JAK2 Exon 12 Mutation Analysis by PCR |
Additional Technical Information |
JAK2 Gene |
Myeloproliferative Neoplasms (MPN), Tumor Markers |
|
0051245 |
JAK2 Gene, V617F Mutation, Qualitative |
Additional Technical Information |
JAK2 Gene |
Myeloproliferative Neoplasms (MPN), Tumor Markers |
|
0040168 |
JAK2 Gene, V617F Mutation, Quantitation |
Additional Technical Information |
JAK2 Gene |
Myeloproliferative Neoplasms (MPN), Tumor Markers |
|
2002695 |
KIT Mutations, Melanoma |
Additional Technical Information |
KIT Mutation |
Melanoma, Tumor Markers, C-KIT, CKIT |
|
0040248 |
KRAS Mutation Detection |
Additional Technical Information |
KRAS Mutation |
Pharmacogenetics (PGx), Lung Cancer, Colorectal Cancer, Tumor Markers, CRC, colon, rectal |
|
2001932 |
KRAS Mutation Detection with BRAF reflex |
Additional Technical Information |
KRAS Mutation |
Pharmacogenetics (PGx), Lung Cancer, Colorectal Cancer, Tumor Markers, CRC, colon, rectal |
|
0055655 |
Methylenetetrahydrofolate Reductase (MTHFR) 2 Mutations |
|
Methylenetetrahydrofolate Reductase (MTHFR) |
MTHFR PCR, Thrombophilia, methotrexate sensitivity, cardiovascular, C677T, A1298C |
|
2003123 |
NRAS Mutation Detection by Pyrosequencing |
Additional Technical Information |
NRAS Mutation |
Colorectal, melanoma, Hereditary Nonpolyposis Colorectal Cancer , HNPCC, Tumor Markers, CRC, colon, rectal |
|
2002363 |
PML-RARA Translocation by FISH |
|
Oncology Studies, FISH—Blood and Bone Marrow Panels |
FISH PML, Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia (APL), Tumor Markers |
|
0049218 |
ERBB2 (HER-2/neu) Gene Amplification by FISH, Tissue |
|
Oncology Studies, FISH—Paraffin Block |
HER2FISH, Breast Cancer, Tumor Markers, FISH, herceptin, HER2, HER-2, neu, HER2/neu, pathvision, pathvysion |
|
2002298 |
PDGFRα Rearrangement |
|
PDGFRα/β Rearrangements |
|
|
2002298 |
PDGFRβ Rearrangement |
|
PDGFRα/β Rearrangements |
|
|
2002871 |
PML-RARA Translocation, t(15;17) by RT-PCR, Quantitative |
Additional Technical Information |
PML-RARA Translocation |
Acute Myelogenous Leukemia (AML), Acute Promyelocytic Leukemia (APL) |
|
0092066 |
Thiopurine Methyltransferase, RBC |
Additional Technical Information |
Thiopurine Methyltransferase |
TPMT RBC, Thiopurine Methyltransferase Activity (TPMT), Pharmacogenetics (PGx), Immunosuppressive Drugs, Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD) |
|
2002573 |
TPMT Genotype |
|
Thiopurine Methyltransferase |
TPMT GENO, Thiopurine Methyltransferase Activity (TPMT), Pharmacogenetics (PGx), Immunosuppressive Drugs, Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD) |
|
0051332 |
UDP Glucuronosyltransferase 1A1 (UGT1A1) Genotyping |
|
UGT1A1 Genotyping |
UGT1A1, Irinotecan, Pharmacogenetics (PGx), Colorectal Cancer |
|
2004358 |
Warfarin Genotyping Plus |
|
Warfarin Genotyping |
WARF PLUS |
|
0051370 |
Warfarin Sensitivity (CYP2C9 & VKORC1 ) 3 Mutations |
|
Warfarin Genotyping |
WARF GENO, Warfarin metabolism, Coumadin, Pharmacogenetics (PGx), cytochrome P450 2C9, CYP2C9*2, CYP2C9*3, c.-1639G>A |